Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:February 13, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:February 13, 2024Completed
Condition(s):Alzheimer’s DiseaseLast Updated:March 10, 2017Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:December 7, 2022Recruiting
Condition(s):Post-Traumatic Stress DisorderLast Updated:September 1, 2017Completed
Condition(s):Muscular Atrophy, SpinalLast Updated:October 26, 2023Completed
Condition(s):Huntington DiseaseLast Updated:October 28, 2022Active, not recruiting
Condition(s):Alcohol MisuseLast Updated:November 18, 2021Unknown status
Condition(s):Medication-Induced DyskinesiaLast Updated:March 20, 2023Completed
Condition(s):Borderline Personality DisorderLast Updated:July 5, 2022Completed
Condition(s):Borderline Personality DisorderLast Updated:September 28, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.